Natural killer cell activating receptor (NK cell activating receptor (no widely used single abbreviation; sometimes referred to by specific receptor names such as NKG2D, NCRs))

Natural killer cell activating receptors are a group of surface molecules expressed on natural killer (NK) cells that mediate their ability to recognize and destroy abnormal target cells such as virus-infected or cancerous cells. These include several families such as C-type lectin-like receptors like NKG2D and immunoglobulin superfamily members known as natural cytotoxicity receptors (NCRs; e.g., NKp30, NKp44, NKp46). Additional important activators include CD16 for antibody-dependent cellular cytotoxicity and certain Toll-like receptors that sense pathogen-associated molecular patterns[3][7]. Activation occurs when these stimulatory signals outweigh inhibitory inputs from other surface molecules recognizing self-markers like MHC class I. Upon sufficient activation signal integration, the NK cell releases perforin and granzymes leading to direct lysis of the target cell and secretes cytokines that further orchestrate immune responses[1][4]. Therapeutic strategies often aim at tipping this balance toward increased activation in diseases like cancer by blocking inhibitory checkpoints rather than directly stimulating these diverse activating pathways[6]. **Note:** "Immune system stimulation (NK cell activation)" is not itself a canonical molecular target but refers collectively to this family/function. For structured data purposes it should be mapped instead onto one or more specific "natural killer cell activating receptor" entities with appropriate subtypes where possible.

Other names

Activating natural killer cell receptorNK-activating receptorNKG2DNatural cytotoxicity receptors (NCRs)CD16Toll-like receptors (on NK cells)

Blockade of inhibitory signals to favor activation of NK cells for cytotoxic activity against target cells[1][6]